Barbora Gromova
Overview
Explore the profile of Barbora Gromova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belvoncikova P, Fejes A, Gromova B, Janovicova L, Farkasova A, Babal P, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076519
Alcohol-related liver disease (ALD) is a leading cause of chronic liver conditions globally. Chronic alcohol consumption induces liver damage through various mechanisms, including neutrophil extracellular trap (NET) formation. Extracellular DNA...
2.
Gao L, Zhang W, Zhang L, Gromova B, Chen G, Csizmadia E, et al.
J Autoimmun
. 2023 Dec;
143:103162.
PMID: 38142533
Th17-cells play a key role in the pathogenesis of autoimmune hepatitis (AIH). Dysregulation of Th17-cells in AIH is linked to defective response to aryl-hydrocarbon-receptor (AhR) activation. AhR modulates adaptive immunity...
3.
Janovicova L, Kmetova K, Pribulova N, Janko J, Gromova B, Gardlik R, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36769306
Deoxyribonucleases (DNases) cleave extracellular DNA (ecDNA) and are under intense research as interventions for diseases associated with high ecDNA, such as acute live injury. DNase I treatment decreases morbidity and...
4.
Liptak R, Gromova B, Gardlik R
Front Med (Lausanne)
. 2021 Sep;
8:665520.
PMID: 34557498
Fecal microbiota transplantation has been primarily investigated as a therapeutic tool for a number of gut disorders. Optimistic results from clinical studies on Clostridium difficile infection, inflammatory bowel disease and...
5.
Maronek M, Gromova B, Liptak R, Konecna B, Pastorek M, Cechova B, et al.
Cells
. 2021 Jan;
10(1).
PMID: 33418977
Circulating extracellular DNA (ecDNA) is known to worsen the outcome of many diseases. ecDNA released from neutrophils during infection or inflammation is present in the form of neutrophil extracellular traps...
6.
Vrablicova Z, Tomova K, Tothova L, Babickova J, Gromova B, Konecna B, et al.
Front Med (Lausanne)
. 2020 Dec;
7:593316.
PMID: 33381513
The role of cell-free DNA (cfDNA) in the pathogenesis of inflammatory bowel disease (IBD) has been recently suggested. The aim of this study was to analyze circulating cfDNA and deoxyribonuclease...
7.
Harshe R, Xie A, Vuerich M, Frank L, Gromova B, Zhang H, et al.
Nat Commun
. 2020 Nov;
11(1):5894.
PMID: 33208731
CD39 is an ectonucleotidase that initiates conversion of extracellular nucleotides into immunosuppressive adenosine. CD39 is expressed by regulatory T (Treg)-cells, where it mediates immunosuppression, and by a subset of T-helper...
8.
Vuerich M, Harshe R, Frank L, Mukherjee S, Gromova B, Csizmadia E, et al.
J Hepatol
. 2020 Jul;
74(1):48-57.
PMID: 32663496
Background & Aims: In autoimmune hepatitis (AIH), the imbalance between regulatory T cells (Tregs) and T-helper type 17 (Th17) cells has been linked to low levels of CD39, an ectoenzyme...
9.
Liptak R, Gromova B, Maronek M, Gardlik R
Med Hypotheses
. 2018 Dec;
122:41-44.
PMID: 30593419
Inflammatory bowel disease (IBD) is characterized by a disbalance in the composition of intestinal microbiota. It is not clear whether such dysbiosis is a cause or a consequence of a...